2026-01-22 - Analysis Report
**Report for Dollar General (DG)**


### 1. Comparison with S&P 500 (VOO)

* Ticker: DG
* Company Name: Dollar General
* Cumulative Return of Review Stock: -2.41%
* Cumulative Return of Comparison Stock (S&P 500, VOO): 91.55%
* Divergence (max: 60.40, min: -128.30, current: -94.70, relative divergence: 17.80%)
Dollar General's stock has underperformed the S&P 500 with a cumulative return of -2.41% compared to 91.55% for VOO. The relative divergence of -94.70 is within the 17.80% range.

### Alpha, Beta Analysis

| **Year** | **CAGR** | **MDD** | **Alpha** | **Beta** | **Cap(B)** |
|---------|---------|--------|-----------|---------|-----------|
| 2016-2018| 26.0%   | 20.0%  | 21.0%     | 0.8     | 23.8B     |
| 2017-2019| 57.0%   | 11.6%  | 40.0%     | 0.8     | 34.3B     |
| 2018-2020| 6.0%    | 16.7%  | -15.0%    | 0.6     | 46.3B     |
| 2019-2021| 15.0%   | 20.7%  | -29.0%    | 0.5     | 51.9B     |
| 2020-2022| 17.0%   | 20.7%  | 19.0%     | 0.6     | 54.2B     |
| 2021-2023| -42.0%  | 56.3%  | -43.0%    | 0.6     | 29.9B     |
| 2022-2024| -84.0%  | 61.6%  | -104.0%   | 0.5     | 16.7B     |
| 2023-2025| -70.0%  | 59.4%  | -132.0%   | 0.1     | 29.2B     |

### 2. Stock Price Fluctuations

* Close: $147.16
* Last-Market: $147.16 -> $146.63 (change: $0.53, but corrected in text: $0.36)
* 5-day SMA: $149.04
* 20-day SMA: $142.36
* 60-day SMA: $121.72
The stock has a 5-day SMA of $149.04 and a 20-day SMA of $142.36. The 60-day SMA is at $121.72.

### 3. RSI, PPO Index Indicators and Delta_Previous_Relative_Divergence, Expected_Return

* Market Risk Indicator (MRI): 0.80
* RSI: 67.12
* PPO: -0.49
* Hybrid Signal: Buy (Cash 0%)
* Risk Level: Medium (MRI 0.80)
* Recent (20 days) relative divergence change: 2.40 (+)
* 7-day Rank change: 42 (+)
* 7-day Dynamic Expected Return change: -15.50 (-)
* Expected Return (%): -221.80%
The stock has a medium risk level (MRI 0.80) and a buy signal (RSI 67.12 and PPO -0.49). The recent 20-day relative divergence change is 2.40 (+), indicating improvement. The 7-day rank change is 42 (+), but the 7-day dynamic expected return change is -15.50 (-), indicating a worsening return expectation. The expected return is -221.80%.

### 4. Recent News & Significant Events (Yahoo Finance)

* [2026-01-21] What Makes Dollar General (DG) a Strong Momentum Stock: Buy Now? - Yahoo Finance
* [2025-12-18] Dollar General's Turnaround Could Send the Stock Higher in 2026 - MarketBeat
* [2026-01-19] 1 Safe-and-Steady Stock with Exciting Potential and 2 We Find Risky - The Globe and Mail
* [2026-01-20] How Dollar General Corporation (DG) Affects Rotational Strategy Timing - Stock Traders Daily
* [2026-01-16] Dollar General (DG) Valuation Check After Sharply Divergent Short And Long Term Shareholder Returns - simplywall.st
* [2026-01-12] DG or ROST: Which Is the Better Value Stock Right Now? - Nasdaq

### Analyst Opinions

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.29 (~Buy)
- Opinions: 28
- Target Price (avg/high/low): 138.43 / 170.00 / 80.00

### 5. Recent Earnings Analysis

| **Date** | **EPS** | **Revenue** |
|---------|--------|-------------|
| 2025-12-04| 1.28   | $10.65 B$   |
| 2025-08-28| 1.87   | $10.73 B$   |
| 2025-06-03| 1.78   | $10.44 B$   |
| 2024-12-05| 0.89   | $10.18 B$   |
| 2025-12-04| 0.89   | $10.18 B$   |

The revenue has been relatively stable with a slight increase. The EPS also increased with some fluctuations.

### 6. Financial Information = 5. Financial Information: Revenue and Profitability

| **Quarter** | **Revenue** | **Profit Margin** |
|-------------|-------------|------------------|
| 2025-10-31  | $10.65 B$   | 29.90%           |
| 2025-07-31  | $10.73 B$   | 31.34%           |
| 2025-04-30  | $10.44 B$   | 30.96%           |
| 2025-01-31  | $10.30 B$   | 29.40%           |
| 2024-10-31  | $10.18 B$   | 28.83%           |

### Comprehensive Analysis (Summary of previous items)

Dollar General has a negative cumulative return of -2.41% compared to the S&P 500's 91.55%. The Alpha, Beta analysis shows a decline in performance with a medium risk level (MRI 0.80) and a buy signal (RSI 67.12 and PPO -0.49). The recent earnings analysis shows a relatively stable revenue with some fluctuations in EPS. The financial information shows a slight increase in revenue with varying profit margins.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.